Malaise M G, Davin J C, Mahieu P R, Franchimont P
Clin Immunol Immunopathol. 1986 Aug;40(2):356-64. doi: 10.1016/0090-1229(86)90040-1.
Titers of circulating antigalactosyl antibodies (a-Gal Ab) were assessed by passive hemagglutination using rabbit red blood cells in 40 normal subjects, in 14 patients with immunodeficient states, in 47 patients with active rheumatoid arthritis (RA), and in 15 patients with an Henoch-Schönlein disease (HS). Titers of controls ranged from 1:16 to 1:64. All immunodeficient patients exhibited very low titers (1:1). On the contrary, the existence of an enhanced humoral immune response status, as observed in RA, was not reflected by a parallel increase of a-Gal Ab titers. However, in this disease, a strong relationship existed between titers exceeding control values (greater than 1:64) and the prior occurrence of renal injury under gold or D-penicillamine therapy. Lastly, the discovery of elevated titers (greater than 1:64) in HS only when renal involvement occurred further suggests that such antibodies reflect a renal injury.
采用兔红细胞被动血凝法,对40名正常受试者、14名免疫缺陷状态患者、47名活动期类风湿关节炎(RA)患者以及15名过敏性紫癜(HS)患者的循环抗半乳糖基抗体(a-Gal Ab)滴度进行了评估。对照组的滴度范围为1:16至1:64。所有免疫缺陷患者的滴度都非常低(1:1)。相反,在RA中观察到的体液免疫反应增强状态,并未表现为a-Gal Ab滴度的相应升高。然而,在这种疾病中,滴度超过对照值(大于1:64)与金制剂或青霉胺治疗前出现的肾损伤之间存在密切关系。最后,仅在HS出现肾脏受累时才发现滴度升高(大于1:64),这进一步表明此类抗体反映了肾损伤。